Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT01351415

Public ClinicalTrials.gov record NCT01351415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Phase IIIb Trial Evaluating the Efficacy and Safety of Standard of Care +/- Continuous Bevacizumab Treatment Beyond Progression of Disease (PD) in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) After First Line Treatment With Bevacizumab Plus a Platinum Doublet-containing Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label, randomized, multicenter study will evaluate the efficacy and safety of bevacizumab (Avastin) in combination with standard of care (SOC) treatment in participants with advanced non-squamous NSCLC. Participants will be enrolled at documentation of progression of disease (PD) after 4-6 cycles of first-line treatment with bevacizumab plus a platinum doublet-containing therapy and a minimum of two cycles of bevacizumab maintenance treatment prior to PD. Participants will be randomly assigned to one of two treatment arms to receive either bevacizumab plus SOC treatment or SOC treatment alone.

Study identification

NCT ID
NCT01351415
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
485 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2011 (Actual)
Primary completion
Jun 25, 2016 (Actual)
Completion
Jun 25, 2016 (Actual)
Last update posted
Sep 18, 2017

2011 – 2016

United States locations

U.S. sites
68
U.S. states
31
U.S. cities
64
Facility City State ZIP Site status
USA Mitchell Cancer Institute Mobile Alabama 36688 —
Palo Verde Hema/Onc Glendale Arizona 85304 —
Arizona Center for Cancer Care Glendale Arizona 85306 —
Clopton Clinic Jonesboro Arkansas 72401 —
East Valley Hematology ; Oncology Medical Group Burbank California 91505 —
California Cancer Associates for Research & Excellence, Inc. Encinitas California 92008 —
Scripps Clinic; Hematology & Oncology La Jolla California 92037-1027 —
Sutter Cancer Center Sacramento California 95816 —
Coastal Integrative Cancer Care San Luis Obispo California 93401 —
Innovative Clinical Research Institute Whittier California 90603 —
The Hospital of Central CT New Britain Connecticut 06050 —
Eastern Ct Hema/Onco Assoc; Dept of Oncology Norwich Connecticut 06360 —
Lynn Cancer Institute - West Boca Raton Florida 33428 —
Baptist - MD Anderson Cancer Center Jacksonville Florida 32207 —
Cancer Specialists; North Florida ;Jacksonville (AC Skinner Pkwy) Jacksonville Florida 32256 —
Mount Sinai Medical Center Miami Beach Florida 33140 —
Cancer Care Centers of Brevard Rockledge Florida 32955 —
Emory Univ Winship Cancer Inst Atlanta Georgia 30322 —
Summit Cancer Care PC Savannah Georgia 31405 —
Kootenai Cancer Center Post Falls Idaho 83854 —
Alexian Brothers Neurosci Inst Elk Grove Village Illinois 60007 —
Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr Evanston Illinois 60201 —
Joliet Oncology Hematology Associates, Ltd. Joliet Illinois 60435 —
Cancer Care & Hematology; Specialists of Chicagoland Niles Illinois 60714 —
W. Suburban Ctr for Cncer Care River Forest Illinois 60305 —
St. Francis Medical Group Indianapolis Indiana 46237 —
Oncology Hematology Associates of Southwest Indiana Newburgh Indiana 47630 —
McFarland Clinic Ames Iowa 50010 —
Cancer Center of Kansas Wichita Kansas 67214-3728 —
University of Kentucky Medical Center Lexington Kentucky 40536 —
Jewish Cancer Care Louisville Kentucky 40245 —
Hematology/Oncology Clinic, LLP Baton Rouge Louisiana 70809 —
Louisiana Oncology Associates Lafayette Louisiana 70508 —
New England Cancer Specialists Scarborough Maine 04074 —
York Hospital York Village Maine 03909 —
Anne Arundel Health System Research Instit-Annapolis Oncology Ctr Annapolis Maryland 21401 —
Tufts Medical Center; Neely Cancer Center Boston Massachusetts 02111 —
Ann Arbor Hematology Oncology Ann Arbor Michigan 48106 —
Henry Ford Hospital; Hematology Oncology Detroit Michigan 48202 —
Cancer & Hematology Center of West Michigan Grand Rapids Michigan 49546 —
Metro-Minnesota CCOP Saint Louis Park Minnesota 55416 —
St Joseph Oncology Saint Joseph Missouri 64507 —
Heartland CCOP/Missouri Baptist Medical Center St Louis Missouri 63131 —
Stony Brook Univ Cancer Ctr; Medical Oncology Clinic Stony Brook New York 11794-9447 —
Carolina Oncology Specialists, PA - Hickory Hickory North Carolina 28602 —
Aultman Hospital Canton Ohio 44710 —
Mid Ohio Onc Hematology Inc Columbus Ohio 43219 —
Dayton Clinical Oncology Prog Dayton Ohio 45420 —
Signal Point Clinical; Research Center, LLC Middletown Ohio 45042 —
Toledo Hospital; CCOP Toledo Toledo Ohio 43617 —
Bay Area Hospital Coos Bay Oregon 97420 —
St. Lukes Hospital and Health Network Bethlehem Pennsylvania 18015 —
Hematology & Oncology Assoc; North Eastern Pennsylvania Dunmore Pennsylvania 18512 —
St. Mary Medical Center Langhorne Pennsylvania 19047 —
University of Pennsylvania; Radiation Oncology Philadelphia Pennsylvania 19104 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Lankenau Hospital Wynnewood Pennsylvania 19096 —
Memorial Hospital of Rhode Island Pawtucket Rhode Island 02860 —
West Clinic Germantown Tennessee 38138 —
University of Tennessee Medical Center Cancer Institute Knoxville Tennessee 37920 —
Unv of TX SW Med Cntr; Hematology/Onc Dallas Texas 75390-9015 —
Delta Hematology/ Oncology Associates Portsmouth Virginia 23704 —
Blue Ridge Cancer Care - Roanoke Roanoke Virginia 24014 —
Medical Oncology Associates Spokane Washington 99208 —
Fox Valley Hema and Onc SC Appleton Wisconsin 54915 —
Gundersen Lutheran La Crosse Wisconsin 54601 —
UNI OF WISCONSIN SCHOOL OF MEDICINE; GI Oncology Research Group, Paul P Carbone Cancer Center Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01351415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2017 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01351415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →